Introduction
Gastroesophageal reflux disease (GERD) is a chronic condition characterized by reflux of gastric contents into the esophagus, resulting in symptoms such as heartburn, regurgitation, chest discomfort, and impaired quality of life. Modern pathophysiology attributes GERD to lower esophageal sphincter (LES) dysfunction, delayed gastric emptying, increased transient LES relaxations, and impaired esophageal mucosal defense.1 While acid suppression with proton pump inhibitors remains the mainstay of therapy, a significant subset of patients experience partial response, symptom recurrence, or adverse effects with long-term use.
In this context, traditional Ayurvedic formulations are increasingly being explored as adjunctive therapies.
Among these, Patolashunthi Ghrita-a medicated ghee preparation containing Patola (Trichosanthes dioica) and Shunthi (Zingiber officinale) as key components-has been traditionally indicated in conditions associated with impaired digestion, inflammation, and Pitta imbalance. Its potential role in GERD is attributed to its multidimensional effects on gastrointestinal function and mucosal protection.
Composition and Ayurvedic rationale
Patolashunthi Ghrita is prepared using clarified butter (ghrita) processed with decoctions and paste of:
- Patola (Trichosanthes dioica)
- Shunthi (Zingiber officinale, dried ginger)
- Additional supportive herbs depending on classical formulations (varies across textual references)
From an Ayurvedic perspective, GERD-like symptoms are often correlated with Amla Pitta and aggravated Pitta-Vata imbalance, leading to acid-related burning sensations, reflux, and mucosal irritation. Patola is considered Pitta-pacifying and detoxifying, while Shunthi enhances Agni (digestive fire) without aggravating acidity when processed in ghrita. The lipid-based ghrita medium further enhances bioavailability and provides a soothing effect on the inflamed gastrointestinal mucosa.
Mechanisms relevant to GERD
- Gastroprotective and mucosal healing effects: Ghrita serves as an excellent lipid carrier that enhances mucosal coating and protects the esophageal and gastric lining from acid-induced injury. Patola contains bioactive compounds with anti-inflammatory and antioxidant properties that may help reduce epithelial damage. This protective barrier effect is particularly relevant in GERD, where mucosal integrity is compromised due to repeated acid exposure.
- Anti-inflammatory action: Chronic esophageal inflammation plays a central role in GERD symptom persistence. Shunthi (ginger) contains gingerols and shogaols, which are known to inhibit inflammatory pathways including cyclooxygenase (COX) and lipoxygenase (LOX). This may reduce cytokine-mediated mucosal inflammation and alleviate symptoms such as burning sensation and discomfort.
- Prokinetic and digestive regulatory effects: Delayed gastric emptying contributes to increased gastric pressure and reflux episodes. Shunthi is known for its prokinetic activity, enhancing gastric motility and facilitating efficient digestion. Improved gastric clearance may reduce the frequency of reflux events and postprandial symptoms.
- Antioxidant activity: Oxidative stress is increasingly recognized as a contributing factor in GERD-related mucosal injury. Both Patola and Shunthi possess antioxidant properties that may help neutralize reactive oxygen species (ROS), thereby reducing epithelial damage and supporting mucosal repair.
- Pitta-modulating and soothing effects: From an Ayurvedic standpoint, ghrita acts as a cooling and demulcent base, counteracting excessive gastric irritation associated with Pitta aggravation. This may translate into symptomatic relief from heartburn and epigastric burning.
Clinical perspective and limitations
Although Patolashunthi Ghrita is widely referenced in Ayurvedic practice for gastrointestinal disorders, high-quality randomized controlled trials specifically evaluating its efficacy in GERD are limited. Most evidence is extrapolated from its traditional use in dyspepsia, gastritis, and hyperacidity-related conditions. Therefore, its role in GERD should be considered adjunctive rather than substitutive to standard medical therapy.
Standardization of formulation, dose optimization, and pharmacokinetic profiling remain important areas for future research. Additionally, safety monitoring is essential, particularly in long-term use and in patients with metabolic comorbidities.
Conclusion
Patolashunthi Ghrita represents a classical Ayurvedic formulation with potential therapeutic relevance in GERD due to its combined gastroprotective, anti-inflammatory, antioxidant, and prokinetic properties. By addressing both mucosal injury and functional disturbances of digestion, it offers a multi-targeted approach aligned with the complex pathophysiology of GERD. While preliminary mechanistic understanding and traditional use support its clinical potential, robust clinical trials are needed to validate its efficacy and establish its role within integrative GERD management strategies.2
References:
- Tanvir F, Nijjar GS, Aulakh SK, et al. Gastroesophageal Reflux Disease: New Insights and Treatment Approaches. Cureus. 2024;16(8):e67654. Published 2024 Aug 24. doi:10.7759/cureus.67654 https://pmc.ncbi.nlm.nih.gov/articles/PMC11417972/
- Phanibandh YA, Anchalakar SS. Patolashunthi Ghrita in the Management of Urdhwaga Amlapitta (Gastroesophageal Reflux Disease): A Comprehensive Literature Review. World J. Pharm. Res. 2026;15(10):1308-1328. DOI: 10.5281/zenodo.20265331. https://wjpr.s3.ap-south-1.amazonaws.com/article_issue/ce10809c3f2fd0609ec3dea4687170ba.pdf